- LatestEradication of female genital mutilation "a matter of resources"
- LatestHuman rights organisations call for EU action to combat female genital mutilation
- LatestPatau and Edwards syndromes 'can be identified at 10 weeks' gestation'
- LatestFIGO supports 2012’s International Day of Zero Tolerance to Female Genital Mutilation (6 February 2012)
- LatestAbstract Submission and ‘Early Registration’ fee deadline dates extended for FIGO 2012 World Congress
- LatestApplication process now open: FIGO/Olympus training courses in minimally invasive surgical techniques
Ovarian cancer flaw 'identified'
Researchers claim to have identified a genetic flaw which leads to higher risks of suffering from ovarian cancer.
Scientists at the Cancer Research UK Genetic Epidemiology Unit at the University of Cambridge and University College London said the risk of developing cancer increases by 40 per cent when women have both copies of the flaw.
Around 15 per cent of the female population are in this position, the researchers report in Nature Genetics.
Women carrying the chromosome nine variation on both genes have a 14 in 1,000 chance of developing ovarian cancer, it is reported, compared with ten in 1,000 for those who do not.
Dr Simon Gayther from UCL, who worked on the study, said: "There is now a genuine hope that as we find more genetic variants, we can start to identify the women at greatest risk and this could help doctors to diagnose the disease earlier when treatment has a better chance of being successful."
According to researchers at the University of Kentucky Chandler Medical Center and Markey Cancer Center, US, ultrasound techniques are better at predicting occurrences of ovarian cancer than symptom analysis.


![Sift.com [Opens in a new window]](/sites/www.figo.org/themes/figocorp/images/footer-sift-logo.gif)